All News about Alkermes Plc
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://images.pexels.com/photos/4033021/pexels-photo-4033021.jpeg?auto=compress&cs=tinysrgb&dpr=1&w=500)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU33.jpg)
![](https://www.investors.com/wp-content/uploads/2019/10/stock-Seattle-Genetics-02-shutter.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_111.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Alkermes Earnings Preview
February 15, 2023
Via Benzinga
Analyst Ratings for Alkermes
December 06, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/02/alkermes-waltham.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_6784.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_3514.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_29105.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2022
November 03, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_9293.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_5626.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2022
October 14, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/10/14/image-dominos.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_1276.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_2233.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/27/biotech3.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_3822.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2018/12/stock-medical-trials-01-adobe.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Sarissa Capital Comments on Alkermes Annual Meeting
July 06, 2022
Via Business Wire
![](https://www.investors.com/wp-content/uploads/2022/07/Stock-watchingstocks-01-adobe.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU4.jpg)
![](https://staticx-tuner.zacks.com/images/articles/main/85/388.jpg)
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/images/060322_-_Alkermes_-_1654264495325.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/06/05/biotech8.jpg?width=1200&height=800&fit=crop)
![](https://beststocks.com/wp-content/uploads/2021/06/gettyimages-523155194.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/images/052622_-_Alkermes_-_1653580814684.jpg)
Global Central Nervous System Treatment Market Is Expected to Reach $166 Billion In 2028
May 26, 2022
Exposures
COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.